{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for nonoxynol root_references_@count in root_references_@count (approximate match)
Status:
Possibly Marketed Outside US
Source:
505G(a)(3)
(2024)
Source URL:
First approved in 2024
Source:
505G(a)(3)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
505G(a)(3)
(2024)
Source URL:
First approved in 2021
Source:
Varecell Intensive Liposome Serum by D&S Cosmedique Co.Ltd
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
MUTIAN Xraphconn by Nantong MUTIAN Biotechnology Co., Ltd
(2019)
Source URL:
First approved in 2019
Source:
MUTIAN Xraphconn by Nantong MUTIAN Biotechnology Co., Ltd
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
21 CFR 347
(2015)
Source URL:
First approved in 2015
Source:
21 CFR 347
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2013)
Source URL:
First approved in 2013
Source:
21 CFR 352
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT00378729: Phase 4 Interventional Unknown status Polycystic Ovary Syndrome
(2006)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT02171338: Phase 4 Interventional Unknown status Pneumonia
(2013)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Class:
PROTEIN
Status:
Discontinued
Source:
Cholecystokinin Inj 75unit/vial by Ferring Pharmaceuticals [Canada]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
NUCLEIC ACID
